[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

SpringWorks Therapeutics, Inc. Common Stock (SWTX)

SpringWorks Therapeutics (SWTX) is up XXX% today due to strong M&A interest and positive social media buzz. The European Commission conditionally approved EZMEKLY (mirdametinib) for treating NF1-PN.

About SpringWorks Therapeutics, Inc. Common Stock

SpringWorks Therapeutics, Inc. Common Stock (SWTX) is a biopharmaceutical company.
SpringWorks Therapeutics, Inc. Common Stock uses the ticker $SWTX for trading. Listed in the Stocks and category within the Healthcare sectors.

Insights #

SpringWorks Therapeutics, Inc. Common Stock (SWTX) social dominance is up XXXXX% from the previous week.
SpringWorks Therapeutics, Inc. Common Stock (SWTX) galaxy score™ is up XXX% from the previous week.
SpringWorks Therapeutics, Inc. Common Stock (SWTX) posts created is up XXXXXX% from the previous month.

Price: $XX #

Price 24-Hour Chart Data
The stock price is up XXX% today, trading at $47, due to positive social media sentiment surrounding the Merck KGaA acquisition and strong M&A interest, which is further supported by high engagement from investors and traders on X (formerly Twitter).

30-Day
XXXX%

1-Year High: $XXXXX on 2025-02-20
1-Year Low: $XXXXX on 2024-10-23

AltRank: XXX #

AltRank Line Chart
AltRank 24-Hour Chart Data
SpringWorks Therapeutics, Inc. Common Stock (SWTX) is currently AltRank #368 based on combined combined social and market metrics Daily Average: XXX
1 Week: XXXXX +1,086
1 Month: XXXXX +1,286
6 Months: XXXXX +1,092
1 Year: XXXXX +787
1-Year High: XXXXX on 2025-07-22
1-Year Low: XX on 2025-03-01

Galaxy Score: XXXXX #

Galaxy Score Line Chart
Galaxy Score 24-Hour Chart Data
Current Value: XXXXX
Daily Average: XX
1 Week: XX +20
1 Month: XX -XX
6 Months: XX no change
1 Year: XX +2
1-Year High: XX on 2024-11-27
1-Year Low: XX on 2025-03-16

Engagements: XXXXX #

Engagements Line Chart
Engagements 24-Hour Chart Data
Current Value: XXXXX
Daily Average: XXXXXX
1 Week: XXXXXX -XX%
1 Month: XXXXXXX -XX%
6 Months: XXXXXXXXX +66%
1 Year: XXXXXXXXX +169%
1-Year High: XXXXXXX on 2025-02-20
1-Year Low: XXX on 2024-12-27

Social Network	X
Engagements	XXXXX

Mentions: XX #

Mentions Line Chart
Mentions 24-Hour Chart Data
Current Value: XX
Daily Average: XX
1 Week: XXX -XX%
1 Month: XXX +256%
6 Months: XXXXX +93%
1 Year: XXXXX +228%
1-Year High: XXX on 2025-01-24
1-Year Low: X on 2024-07-31

Social Network	X
Mentions	XX

Creators: XX #

Creators Line Chart
Creators 24-Hour Chart Data
XX unique social accounts have posts mentioning SpringWorks Therapeutics, Inc. Common Stock (SWTX) in the last XX hours which is up XX% from XX in the previous XX hours Daily Average: XX
1 Week: XX -XX%
1 Month: XXX +621%
6 Months: XXXXX +111%
1 Year: XXXXX +329%
1-Year High: XXX on 2025-06-27
1-Year Low: X on 2024-10-03

Sentiment: XXX% #

Sentiment Line Chart
Sentiment 24-Hour Chart Data
Current Value: XXX%
Daily Average: XX%
1 Week: XXX% no change
1 Month: XXX% no change
6 Months: XXX% +75%
1 Year: XXX% +80%
1-Year High: XXX% on 2024-08-04
1-Year Low: XX% on 2025-01-20

Most Supportive Themes

M&A Interest: (30%) The acquisition of SpringWorks Therapeutics is generating positive sentiment.
Options Trading Activity: (15%) High interest in options trading is increasing implied volatility.
Bullish Stock Mentions: (7%) Positive mentions of SWTX in social media are driving sentiment up.

Most Critical Themes

Acquisition Price Concerns: (1.2%) Some users are voicing concerns about the acquisition price of SpringWorks Therapeutics.
Sector Skepticism: (0.3%) There is skepticism regarding the biotech sector in general.
EU Trade Concerns: (0.15%) There are concerns that the acquisition could face EU trade complications.

Network engagement breakdown:

Network	Positive	%	Neutral	%	Negative	%
X	XXX	X%	XXXXX	XX%	X	X%

Total	XXX	X%	XXXXX	XX%	X	X%

Social Dominance: XXXXXXX% #

Social Dominance Line Chart
Social Dominance 24-Hour Chart Data
Current Value: XXXXXXX%
Daily Average: XXXXX%
1 Week: XXXXXXX% +0.0009399999999999999%
1 Month: XXXXXX% -XXXXX%
6 Months: XXXXXX% -XXXXX%
1 Year: XXXXXX% -XXXXX%
1-Year High: XXXXX% on 2025-03-06
1-Year Low: XXXXXX% on 2025-07-15

Market Dominance: XXXXXXX% #

Market Dominance Line Chart
Market Dominance 24-Hour Chart Data
Current Value: XXXXXXX%
Daily Average: X%
1-Year High: XXXXX% on 2025-03-31
1-Year Low: XXXXXXX% on 2024-10-23

Market Cap: $XXXXXXXXXXXXX #

Market Cap Line Chart
Market Cap 24-Hour Chart Data
Current Value: $XXXXXXXXXXXXX
Daily Average: $XXXXXXXXXXXXX
1 Month: $XXXXXXXXXXXXX -$0.42%
6 Months: $XXXXXXXXXXXXX +$31%
1 Year: $XXXXXXXXXXXXX +$29%
1-Year High: $XXXXXXXXXXXXX on 2025-02-20
1-Year Low: $XXXXXXXXXXXXX on 2024-10-23

Top assets mentioned In the posts about SpringWorks Therapeutics, Inc. Common Stock in the last XX hours

Neurocrine Biosciences, Inc. (NBIX) Dawn Protocol (DAWN) Blueprint Medicines Corporation (BPMC) Shakita Inu (SHAK) Lumen Technologies Inc (LUMN) SuperRare (RARE) Bitcoin Incognito (XBI) Merck & Co., Inc. (MRK) Intra-Cellular Therapies Inc. (ITCI)

Top topics mentioned In the posts about SpringWorks Therapeutics, Inc. Common Stock in the last XX hours

stocks, $mor, dawn, btc eth, $vrna, investment, gme, $hnsa, $morf, $cura, $nbix, pltr, amzn, nvda, vir, $kzia, $virx, $zyme, telo, stockmarket, mor, smci, asml, amc, $vstm, $qntm, $dawn, $bpmc, qqq, spy, $sls, $anab, $nktr, $shak, lumen technologies, $lumn, mira, abbv, $rare, money, alt, $crdf, $xers, $xbi, $mrk, stocks healthcare, $hrmy, $tars, $mygn, octo, op, sonn, $bcrx, $mtrx, $prvb, $tptx, $cmrx, $mrkde, acquisition, lzm, $mkdww, $mobxw, $ibac, $tyg, xom, $dq, $uhgww, $migi, $itci, nio, mstr, $imcr, neurocrine biosciences inc, $txo, $lmfa, $aplm, $egrx, $tara, $asmb, $hcm, $nvs, longterm, $poai, $pepg, $amze, $wnc, $bnai, shfs, icu, $bst, $urgn, $vrtx, $rgnx, frog, $6758t, $yy, $rxst, coins healthcare, meta, $gaini